Stocks and Investing Stocks and Investing
Tue, July 9, 2024
Mon, July 8, 2024
Fri, July 5, 2024

Patrick Trucchio Maintained (ARWR) at Strong Buy with Decreased Target to $60 on, Jul 5th, 2024


Published on 2024-10-28 12:15:20 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Decreased Target from $90 to $60 on, Jul 5th, 2024.

Patrick has made no other calls on ARWR in the last 4 months.



There are 4 other peers that have a rating on ARWR. Out of the 4 peers that are also analyzing ARWR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024


These are the ratings of the 2 analyists that currently disagree with Patrick


  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Wednesday, June 26th, 2024
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, June 20th, 2024